Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase development framework - Chiotis, K; Saint-Aubert, L; Boccardi, M (Neurobiol Aging, 2017)
. doi:10.1016/J.NEUROBIOLAGING.2016.07.012